USPTO 2015–2025 USPTO PatentsView US Corporation

Charles R. DREW University OF Medicine AND Science

USPTO PatentsView assignee record - 6 granted patents across 14 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

12.3

Avg claims per patent

+100%

5-year filing velocity

The verdict

Charles holds 6 US patents across 14 technology areas, rank #39,356 of 50,000 tracked assignees.

#39,356
of 50,000 US assignees by volume: Top 54%
by Innovation Score (34.0/100): 12.3
avg claims per patent: +100%
filing velocity, last 5 yrs

Portfolio overview

Charles R. DREW University OF Medicine AND Science has been granted 6 US utility patents between 2015 and 2023, placing Charles R. DREW University OF Medicine AND Science at rank #39,356 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.3 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Charles R. DREW University OF Medicine AND Science is one of the more focused assignees in the PatentsView dataset. By volume, Charles sits between Changhua Christian Medical Foundation Changhua Christian Hospital (6 patents, rank #39,352) and Chemical & Biopharmaceutical Laboratories OF Patras S.a. (6 patents, rank #39,360) - the closest US assignees by grant volume. The composite Innovation Score of 34.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 2 in the 2015–2019 window, a +100% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Charles R. DREW University OF Medicine AND Science's 12.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Charles R. DREW University OF Medicine AND Science against peers pursuing similar technology classes.

Changhua Christia…

6
Changsha Yuwen Ne…

6
Changzhou Sunwood…

6
Channel Master

6
Charming World

6
CHD Holdings

6
Checkpoint Mobile…

6
Chemical & Biopha…

6
Charles R DREW Un… ◀

6

What this shows Charles holds 6 patents at rank #39,356, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Charles

By rank, the assignees closest to #39,356 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Charles's primary technology class.

Charles's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

34 Top 54% higher than 46% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Charles R. DREW University OF Medicine AND Science patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	16.7%
2017	1	16.7%
2021	2	33.3%
2022	1	16.7%
2023	1	16.7%

Which technologies does Charles R. DREW University OF Medicine AND Science patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

C07D - HETEROCYCLIC COMPOUNDS 1

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 1

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 1

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

A61D - VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS 1

A24F - SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES 1

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 1

Top 14 of 14 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#39,356

Across all tracked assignees

Innovation Score

34.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Charles R. DREW University OF Medicine AND Science hold?

Charles R. DREW University OF Medicine AND Science holds 6 US granted patents filed between 2015 and 2023, spanning 14 technology areas.

What is Charles R. DREW University OF Medicine AND Science's Innovation Score?

Charles R. DREW University OF Medicine AND Science has an Innovation Score of 34.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Charles R. DREW University OF Medicine AND Science focus on?

Charles R. DREW University OF Medicine AND Science's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 2 patents. The company has filed patents in 14 CPC subclasses total.

Is Charles R. DREW University OF Medicine AND Science's patent filing rate increasing or decreasing?

Charles R. DREW University OF Medicine AND Science's recent filing velocity is +100% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Charles R. DREW University OF Medicine AND Science's patents?

Charles R. DREW University OF Medicine AND Science's patents average 12.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the Charles R. DREW University OF Medicine AND Science patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Charles's 6 grants land it in the top 54% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Charles ranks #39,356 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.